samedan logo
 
 
spacer
home > ebr > winter 2010 > made in leiden
PUBLICATIONS
European Biopharmaceutical Review

Made in Leiden

The Leiden Bio Science Park is the leading life science cluster in the Netherlands and ranks among the top five most successful science parks in Europe. Currently it is home to over 60 medical and life science companies and features the largest number of biomedical startups on the continent. The stimulating business environment which the park provides has led innovative companies to settle there. It is also home to numerous smaller but promising startups which are on the brink of turning academic discoveries into innovative products. These companies benefit from the high standard of research carried out by Leiden University and Leiden University Medical Center (LUMC), both located at the park. By facilitating access to their knowledge and working closely with the industry, Leiden University and LUMC play a key role in the park’s success.

The Leiden Bio Science Park is located 30 minutes south of Amsterdam, and just 15 minutes away from Schiphol International Airport. Since it was established in 1984, the park grew from housing three companies to over 60 by April 2009. This increase was the result of attracting both Dutch and international companies, spin-offs and startups to the park.

In addition to commercial companies, the park houses several internationally renowned research institutes from Leiden University and LUMC. This combination of research and commercial organisations has enabled businesses to turn scientific discoveries into innovative products, and ensures that research is not only of an extremely high standard, but that it also has high clinical relevance.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Bob Smailes has been engaged in technology transfer for over 20 years, establishing and running TTOs for three universities in the UK and the Netherlands. He has been responsible for several hundred license deals and the establishment of over 60 spin-out companies. He has previously also been the Chairman and/or Director of two pre-seed funds, three incubator companies, two consultancy firms and a science park. He is currently Director of Leiden University Research & Innovation Services (LURIS), and Director of Technology Transfer at Leiden University Medical Center. He is also Director of the University’s holding company, Libertatis Ergo Holding, a Director of two pre-seed funds and a member of the Supervisory Board of BioGeneration Ventures BV. Bob is an active and regular presenter in a number of professional bodies, including the Royal Society of Chemistry, AUTM, LES and SRA. Email: b.smailes@luris.nl
spacer
Dr Bob Smailes
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

CPhI South America

17-19 August 2010, Buenos Aires, Argentina

With the new La Rural Expo Center venue hosting CPhI South America 2010, make sure you don’t miss the opportunity to exhibit in front of one of the fastest growing pharmaceutical markets in the world. As the whole of Latin America seeks to build on its expanding industry, this is your chance to seize an early advantage by establishing crucial networking relationships that will help promote your business.
More info >>

 
News and Press Releases

PharmaBrand Summit 2010

Top pharmaceutical executives shared best practices at the PharmaBrand Summit 2010, which took place on the 21st to 23rd June 2010 in Monte-Carlo, Monaco and was organised by Marcus Evans
More info >>

 

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement